Senate Blocks Medicare Drug Price Negotiation Bill From Floor Vote
This article was originally published in The Pink Sheet Daily
Executive Summary
Sen. Baucus’ effort to simply strike the non-interference clause, rather than requiring negotiations, did not garner enough support to force a vote.
You may also be interested in...
HHS Price Negotiations For Part D Not A Problem For Medco, CEO Snow Says
Medco is not worried about the possibility that the federal government may step in to negotiate drug prices for the Medicare Part D program, according to CEO David Snow
HHS Price Negotiations For Part D Not A Problem For Medco, CEO Snow Says
Medco is not worried about the possibility that the federal government may step in to negotiate drug prices for the Medicare Part D program, according to CEO David Snow
Higher Part D Premiums Whet Waxman’s Appetite For HHS Price Negotiation
Increasing Part D premiums have caught the eye of Rep. Henry Waxman, who sees them as further evidence that HHS would do a better job of negotiating drug prices for Part D than the private sector
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: